First Hawaiian Bank Laboratory Corp Of America Holdings Transaction History

First Hawaiian Bank

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 05, 2024	SELL	$209.01 - $232.56 $81,722 - $90,930	-391 Reduced 5.14%	7,219 $1.58 Million
Q3 2023 Oct 10, 2023	BUY	$201.05 - $221.7 $90,472 - $99,765	450 Added 6.28%	7,610 $1.53 Million
Q2 2023 Jul 06, 2023	SELL	$211.93 - $241.33 $24,371 - $27,752	-115 Reduced 1.58%	7,160 $1.73 Million
Q1 2023 Apr 18, 2023	BUY	$213.32 - $257.83 $1.01 Million - $1.22 Million	4,715 Added 184.18%	7,275 $1.67 Million
Q4 2022 Jan 12, 2023	BUY	$203.72 - $248.97 $521,523 - $637,363	2,560 New	2,560 $602,000
Q2 2019 Jul 15, 2019	SELL	$144.16 - $172.9 $17,587 - $21,093	-122 Closed	0 $0
Q1 2019 Apr 02, 2019	SELL	$123.7 - $156.3 $176,025 - $222,414	-1,423 Reduced 92.1%	122 $19,000
Q4 2018 Jan 11, 2019	SELL	$120.82 - $174.09 $345,182 - $497,375	-2,857 Reduced 64.9%	1,545 $195,000
Q3 2018 Oct 16, 2018	BUY	$167.67 - $188.27 $738,083 - $828,764	4,402 New	4,402 $764,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.3B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

Stay updated on First Hawaiian Bank with notifications on news.